Chemical M&A and Financing Healthy, but Coronavirus Clouds the Outlook (ICIS Chemical Business Feb 14-20, 2020)
Young & Partners authored article that looks at what happened last year in M&A and Financing and the outlook for 2020.
Press Release: Société de Chimie Industrielle Elects Peter Young as President (January 23, 2020)
Leading Chemicals and Life Science industry association elects new officers for 2020
Pharmaceutical Executive “Trends to Watch” issue features Young & Partners (January 2020)
Young & Partners and others discuss the biopharma business and financial ecosystem today and going forward
Chemicals Financing Activity Declines (Y&P article in ICIS Chemical Business Nov 29 – Dec 5, 2019)
Young & Partners documents the decline in debt and equity financing and the underlying trends
Megadeals done, M&A volumes remain flat (Chemical Week July 22, 2019 issue)
Editor-in-Chief interviews Peter Young about the Chemical M&A market developments
Pharma and Biotech – Financial Check and Outlook (Y&P article in Pharma Exec, July 2019 issue)
Young & Partners examples the strategic, M&A, and financial health of Biopharma
Chemicals M&A in Transition (Y&P article in ICIS Chemical Business, June 14-20, 2019)
Analysis of the M&A market: Shifting Valuations, Healthy Volumes, Death of Mega Deals
M&A Values Hold Strong But Volume Dips (Chemweek March 11-18, 2019)
Young & Partners data shows high total dollars in 2018, but underlying volumes slid
Chemicals M&A at Inflection Point (Y&P article in ICIS March 1-7, 2019 issue)
Transaction trends differ greatly, depending on sector and geography.
CFIUS Reform’s Impact on Biopharma (Phama Exec February 2019 issue)
What the new rules mean for Chinese-related investments and acquisitions in the US